Loading organizations...
Key people at Signet Healthcare Partners.
Signet Healthcare Partners provides growth capital to innovative companies across the healthcare sector. The firm concentrates its investments on commercial-stage businesses within specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. They utilize a disciplined investment approach, actively partnering with their portfolio companies to drive value and strategic growth.
The firm was established in 1998 by James Gale, who recognized the need for a focused investment platform in healthcare. Gale’s substantial experience, spanning over three decades in healthcare investing and finance, formed the core insight for Signet. His prior roles in leading principal investment and investment banking activities provided a robust foundation for the firm.
Signet serves growth-stage healthcare companies, predominantly in North America and Europe, including privately held and structured public entities. The firm's vision is to be strategic partners and domain experts, fostering revenue growth and operational leverage within their portfolio. They aim to cultivate leading businesses through collaborative engagement, offering extensive network access and informed strategic guidance.
Key people at Signet Healthcare Partners.
Signet Healthcare Partners has 2 tracked investments across 2 companies. The latest tracked deal is $24.0M Series B in Paragonix Technologies in March 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 7, 2023 | Paragonix Technologies | $24.0M Series B | Ashley Friedman, Signet Healthcare Partners | — |
| Nov 12, 2010 | Arbor Pharmaceuticals | $34.8M Debt / Series B | Signet Healthcare Partners | Arch Healthcare Fund, JW Asset Management |